Animal Pharma
Veterinary clinic groups, hospitals and diagnostic providers serving companion animals and pets
Practical insight at the intersection of clinical practice and commercial strategy
Strengthening Veterinary Groups and Diagnostics for Sustainable Growth
Veterinary clinics, hospitals and diagnostic providers are consolidating rapidly, yet value creation requires more than scale. Operational resilience, clinical credibility and a clear path to differentiation are equally important.
We bring first-hand veterinary knowledge alongside strategy consulting and investment expertise. Our team has worked both in practice and at board level, and has led initiatives from clinic acquisition pipelines through to digital innovation in companion animal care. This dual perspective allows us to assess opportunities with commercial objectivity while respecting the clinical realities that underpin client trust.
Our work spans commercial due diligence, operational strategy, and post-acquisition value creation. We examine practice economics, diagnostic adoption, pricing dynamics, and evolving pet owner expectations, ensuring investment theses reflect on-the-ground realities. Beyond transaction support, we help management teams strengthen culture, streamline operations, and position for sustainable growth.
We also advise on AI, Digital and Data Strategy, go-to-market planning, pricing, commercial excellence, performance improvement and salesforce effectiveness, ensuring clinic groups and diagnostics build both scale and resilience.
Our animal pharma leads
Our teams combine scientific expertise with deal experience. We bring rigour to forecasting and valuation, assess regulatory and market access dynamics, and help frame development strategies that appeal to potential partners or acquirers. This ensures that investment cases are built on realistic assumptions and that transactions are structured to capture fair value.
Beyond transactions, we support operational priorities such as target operating model design, performance improvement, and digital and data strategy. By combining strategic clarity with an understanding of scientific and clinical realities, we help biotech firms and their backers make sound decisions in an increasingly competitive market.
News & Insights
Our animal health Insights
News & Insights
Healthcare news, data and analysis
Via Investors in Healthcare
